Director/PDMR Shareholding

Hikma Pharmaceuticals Plc
02 January 2008


Hikma Pharmaceuticals PLC
2 January 2008

This announcement replaces the RNS 8882K. In statement 13, the price per share
should read 494.9 pence per share not 4.949 pence per share.



NOTIFICATION OF TRANSACTION OF DIRECTOR/PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITY AND CONNECTED PERSONS

This form is intended for use by an issuer to make a RIS notification required 
by DTR 3.1.4R(1).

(1)  An issuer making a notification in respect of a transaction relating to the 
     shares or debentures of the issuer should complete boxes 1 to 16, 23
     and 24.

(2)  An issuer making a notification in respect of a derivative relating the 
     shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23 
     and 24.

(3)  An issuer making a notification in respect of options granted to a 
     director/person discharging managerial responsibilities should complete 
     boxes 1 to 3 and 17 to 24.

(4)  An issuer making a notification in respect of a financial instrument 
     relating to the shares of the issuer (other than a debenture) should 
     complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.


Please complete all relevant boxes should in block capital letters.


1. Name of the issuer

HIKMA PHARMACEUTICALS PLC
....................................


2. State whether the notification relates to (i) a transaction notified in
accordance with DTR 3.1.4R(1)(a); or

(ii) a disclosure made in accordance with LR 9.8.6R(1); or

(iii) a disclosure made in accordance with section 793 of the Companies Act 2006.

(i)
....................................

3. Name of person discharging managerial responsibilities/director

DR RONALD GOODE

....................................

4. State whether notification relates to a person connected with a person
discharging managerial responsibilities/director named in 3 and identify the
connected person

N/A
....................................


5. Indicate whether the notification is in respect of a holding of the person
referred to in 3 or 4 above or in respect  of a non-beneficial interest

3 ABOVE
....................................

6. Description of shares (including class), debentures or derivatives or
financial instruments relating to shares

ORDINARY SHARES OF 10 PENCE EACH
....................................

7. Name of registered shareholders(s) and, if more than one, the number of
shares held by each of them

VIDACOS NOMINEES LIMITED
....................................


8 State the nature of the transaction

PURCHASE OF SHARES

....................................

9. Number of shares, debentures or financial instruments relating to shares
acquired

3,000
....................................


10. Percentage of issued class acquired (treasury shares of that class should
not be taken into account when  calculating percentage)

0.001%
....................................


11. Number of shares, debentures or financial instruments relating to shares 
disposed

N/A
....................................


12. Percentage of issued class disposed (treasury shares of that class should
not be taken into account when  calculating percentage)

N/A
....................................


13. Price per share or value of transaction

494.9 PENCE PER SHARE
....................................


14. Date and place of transaction

28 DECEMBER 2007, LONDON
....................................


15. Total holding following notification and total percentage holding following 
notification (any treasury shares should not be taken into account when 
calculating percentage)

6,000 (0.002%)

....................................

16. Date issuer informed of transaction

28 DECEMBER 2007

....................................

If a person discharging managerial responsibilities has been granted options by 
the issuer complete the following boxes


17 Date of grant

....................................

18. Period during which or date on which it can be exercised

....................................

19. Total amount paid (if any) for grant of the option

....................................

20. Description of shares or debentures involved (class and number)

....................................

21. Exercise price (if fixed at time of grant) or indication that price is to be 
fixed at the time of exercise

....................................

22. Total number of shares or debentures over which options held following
notification

....................................

23. Any additional information

N/A

....................................

24. Name of contact and telephone number for queries

HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760

....................................

Name and signature of duly authorised officer of issuer responsible for making 
notification

HENRY KNOWLES, COMPANY SECRETARY, 020 7399 2760

....................................

Date of notification

2 JANUARY 2008

....................................

END






                      This information is provided by RNS
            The company news service from the London Stock Exchange